Annual Total Debt
$25.23 M
+$2.16 M+9.35%
December 31, 2023
Summary
- As of February 7, 2025, ADAP annual total debt is $25.23 million, with the most recent change of +$2.16 million (+9.35%) on December 31, 2023.
- During the last 3 years, ADAP annual total debt has risen by +$1.52 million (+6.43%).
- ADAP annual total debt is now -0.91% below its all-time high of $25.47 million, reached on December 31, 2021.
Performance
ADAP Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$74.50 M
+$27.15 M+57.34%
September 30, 2024
Summary
- As of February 7, 2025, ADAP quarterly total debt is $74.50 million, with the most recent change of +$27.15 million (+57.34%) on September 30, 2024.
- Over the past year, ADAP quarterly total debt has increased by +$50.80 million (+214.43%).
- ADAP quarterly total debt is now at all-time high.
Performance
ADAP Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
ADAP Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.3% | +214.4% |
| 3 y3 years | +6.4% | +186.8% |
| 5 y5 years | +100.0% | +198.7% |
ADAP Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.9% | +9.3% | at high | +232.6% |
| 5 y | 5-year | -0.9% | +9.3% | at high | +232.6% |
| alltime | all time | -0.9% | -100.0% | at high | -100.0% |
Adaptimmune Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $74.50 M(+57.3%) |
| Jun 2024 | - | $47.35 M(+99.8%) |
| Mar 2024 | - | $23.69 M(-6.1%) |
| Dec 2023 | $25.23 M(+9.4%) | $25.23 M(-1.4%) |
| Sep 2023 | - | $25.60 M(-2.8%) |
| Jun 2023 | - | $26.34 M(+15.4%) |
| Mar 2023 | - | $22.83 M(-1.1%) |
| Dec 2022 | $23.08 M(-9.4%) | $23.08 M(+3.0%) |
| Sep 2022 | - | $22.40 M(-7.4%) |
| Jun 2022 | - | $24.19 M(-6.8%) |
| Mar 2022 | - | $25.95 M(+1.9%) |
| Dec 2021 | $25.47 M(+7.4%) | $25.47 M(-1.9%) |
| Sep 2021 | - | $25.97 M(+14.7%) |
| Jun 2021 | - | $22.64 M(-0.4%) |
| Mar 2021 | - | $22.74 M(-4.1%) |
| Dec 2020 | $23.71 M(-6.9%) | $23.71 M(+0.0%) |
| Sep 2020 | - | $23.71 M(+1.7%) |
| Jun 2020 | - | $23.31 M(-4.6%) |
| Mar 2020 | - | $24.42 M(-4.1%) |
| Dec 2019 | $25.46 M | $25.46 M(+2.1%) |
| Sep 2019 | - | $24.94 M(-4.1%) |
| Jun 2019 | - | $26.00 M(-10.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $29.00 M(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | - |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | $0.00(0.0%) | - |
| Dec 2014 | - | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | $0.00(0.0%) | $0.00 |
| Dec 2013 | $0.00(-100.0%) | - |
| Jun 2013 | $1.54 M(>+9900.0%) | - |
| Jun 2012 | $0.00 | - |
FAQ
- What is Adaptimmune Therapeutics annual total debt?
- What is the all time high annual total debt for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics annual total debt year-on-year change?
- What is Adaptimmune Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly total debt year-on-year change?
What is Adaptimmune Therapeutics annual total debt?
The current annual total debt of ADAP is $25.23 M
What is the all time high annual total debt for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual total debt is $25.47 M
What is Adaptimmune Therapeutics annual total debt year-on-year change?
Over the past year, ADAP annual total debt has changed by +$2.16 M (+9.35%)
What is Adaptimmune Therapeutics quarterly total debt?
The current quarterly total debt of ADAP is $74.50 M
What is the all time high quarterly total debt for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high quarterly total debt is $74.50 M
What is Adaptimmune Therapeutics quarterly total debt year-on-year change?
Over the past year, ADAP quarterly total debt has changed by +$50.80 M (+214.43%)